These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30453342)

  • 1. Comparison of the Effects of Prophylactic and Therapeutic Administrations on Peripheral Neuropathy in Streptozotocin-Diabetic Rats with Gliclazide or Methylcobalamin.
    Yao H; Feng J; Zheng Q; Wei Y; Yang G; Feng W
    Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):635-643. PubMed ID: 30453342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of gliclazide, methylcobalamin, and gliclazide+methylcobalamin combination therapy on diabetic peripheral neuropathy in rats.
    Yao H; Feng J; Zheng Q; Wei Y; Wang S; Feng W
    Life Sci; 2016 Sep; 161():60-8. PubMed ID: 27496624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the beneficial effect of aliskiren in attenuating neuropathic pain in diabetic Sprague-Dawley rats.
    Alkhudhayri S; Sajini R; Alharbi B; Qabbani J; Al-Hindi Y; Fairaq A; Yousef A
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00209. PubMed ID: 33855212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
    Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
    J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis.
    Wu YB; Shi LL; Wu YJ; Xu WH; Wang L; Ren MS
    Neurosci Lett; 2012 Aug; 523(1):45-9. PubMed ID: 22732450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.
    Attia HN; Al-Rasheed NM; Al-Rasheed NM; Maklad YA; Ahmed AA; Kenawy SA
    Behav Pharmacol; 2012 Apr; 23(2):153-61. PubMed ID: 22411174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
    Jian-bo L; Cheng-ya W; Jia-wei C; Xiao-lu L; Zhen-qing F; Hong-tai M
    Nutr Neurosci; 2010 Apr; 13(2):79-86. PubMed ID: 20406575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress.
    Wang X; Huan Y; Li C; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Liu H; Huang K; Zhou J; Shen Z
    Biochem Pharmacol; 2020 Dec; 182():114221. PubMed ID: 32949583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
    Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
    Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocurcumin improved glucose metabolism in streptozotocin-induced diabetic rats: a comparison study with Gliclazide.
    Afifi M; Alkaladi A; Abomughaid MM; Abdelazim AM
    Environ Sci Pollut Res Int; 2020 Jul; 27(20):25271-25277. PubMed ID: 32347481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Matrix Remodeling and Modulation of Inflammation and Oxidative Stress by Sulforaphane in Experimental Diabetic Peripheral Neuropathy.
    Moustafa PE; Abdelkader NF; El Awdan SA; El-Shabrawy OA; Zaki HF
    Inflammation; 2018 Aug; 41(4):1460-1476. PubMed ID: 29704151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
    Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
    Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol effectively ameliorates diabetic peripheral neuropathy in mice.
    Yang J; Wei Y; Zhao T; Li X; Zhao X; Ouyang X; Zhou L; Zhan X; Qian M; Wang J; Shen X
    Phytomedicine; 2022 Dec; 107():154434. PubMed ID: 36122436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy.
    Yang XW; Liu FQ; Guo JJ; Yao WJ; Li QQ; Liu TH; Xu LP
    BMC Complement Altern Med; 2015 Mar; 15():66. PubMed ID: 25887432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
    Han LP; Yu DM; Xie Y
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.
    Prnova MS; Kovacikova L; Svik K; Bezek S; Elmazoğlu Z; Karasu C; Stefek M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):651-661. PubMed ID: 31802170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.